Clinical Trials Directory

Trials / Conditions / Ovarian Neoplasm Epithelial

Ovarian Neoplasm Epithelial

12 registered clinical trials studyying Ovarian Neoplasm Epithelial — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingOV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
NCT06466382
Swiss GO Trial GroupN/A
RecruitingPharmacokinetic Study of Tranexamic Acid
NCT06728670
Zhejiang Cancer HospitalN/A
UnknownMIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer
NCT05960630
Royal Surrey County Hospital NHS Foundation TrustN/A
Active Not RecruitingOregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovar
NCT05605535
CanariaBio Inc.Phase 2
TerminatedA Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
NCT05001282
Elucida OncologyPhase 1 / Phase 2
RecruitingMAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
NCT04111978
Swiss GO Trial GroupPhase 3
UnknownMinimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival
NCT04402333
Royal Surrey County Hospital NHS Foundation Trust—
TerminatedFunctional Analysis of BRCAness
NCT04780945
Leiden University Medical CenterPhase 2
UnknownBortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer P
NCT03509246
Seoul National University HospitalPhase 2
CompletedThe Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery
NCT06103214
Zhejiang Cancer HospitalN/A
UnknownInherited Susceptible Genes Among Epithelial Ovarian Cancer
NCT03015376
Peking Union Medical College Hospital—
UnknownSub-type Specific Genomic Mutations in sBOTs
NCT03883542
Universitair Ziekenhuis Brussel—